GTR 62805023
Tenders Are Invited For Pharmaceutical Products (Mono (Province D/Int. 1 Mg/Ml Amp. 5 Ml, Blister In A Pack (L-Lysine Escinate)), Thioctic Acid (Province D/Inf. 3% Amp. 20 Ml, Blister In A Pack), Amoxicillin And Beta-Lactamase Inhibitor (Cf. D/Oral Suspension 250 Mg/5 Ml + 62.5 Mg/5 Ml Fl., D/P 100 Ml Suspension), Magnesium (Different Salts In Combination ) (Tab. Blister In A Pack), Betamethasone (R-N D/In. 4 Mg/Ml Amp. 1 Ml, Pack), Budesonide (Susp. D/Spray. 0.5 Mg/Ml Container 2 Ml), Salbutamol (R-N D/Ing. 2.5 Mg Nebula 2.5 Ml), Tocopherol (Vit E) (Caps. Soft 400 Mg Blister), Ademetionine (Lyophil. D/R-Nu D/In. 500 Mg Fl., In A Set With Solution. Amp. 5 Ml), Hydazepam (Tab. 0.02 G Blister), Dexketoprofen (R-N D/In. 50 Mg/2 Ml Amp. 2 Ml, Contour Cell Pack. .), Dexmedetomidine (Concent. D/R-Nu D/Inf. 100 Μg/Ml Amp. 2 Ml), Diphenhydramine (R-N D/In. 10 Mg/Ml Amp. 1 Ml, Contour. Cell. Yp. , Pack), Urapidil (Province D/In. 25 Mg Amp. 5 Ml), Escitalopram (Tablet In/Film-Coated 10 Mg Bliste
ICB — International Competitive Bid
Closed
Eastern Europe
Tender Information
GTR Reference
62805023
Tendering Authority
Subscribe to view
Tender No
UA-2023-03-30-007684-a
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products (Mono (Province D/Int. 1 Mg/Ml Amp. 5 Ml, Blister In A Pack (L-Lysine Escinate)), Thioctic Acid (Province D/Inf. 3% Amp. 20 Ml, Blister In A Pack), Amoxicillin And Beta-Lactamase Inhibitor (Cf. D/Oral Suspension 250 Mg/5 Ml + 62.5 Mg/5 Ml Fl., D/P 100 Ml Suspension), Magnesium (Different Salts In Combination ) (Tab. Blister In A Pack), Betamethasone (R-N D/In. 4 Mg/Ml Amp. 1 Ml, Pack), Budesonide (Susp. D/Spray. 0.5 Mg/Ml Container 2 Ml), Salbutamol (R-N D/Ing. 2.5 Mg Nebula 2.5 Ml), Tocopherol (Vit E) (Caps. Soft 400 Mg Blister), Ademetionine (Lyophil. D/R-Nu D/In. 500 Mg Fl., In A Set With Solution. Amp. 5 Ml), Hydazepam (Tab. 0.02 G Blister), Dexketoprofen (R-N D/In. 50 Mg/2 Ml Amp. 2 Ml, Contour Cell Pack. .), Dexmedetomidine (Concent. D/R-Nu D/Inf. 100 Μg/Ml Amp. 2 Ml), Diphenhydramine (R-N D/In. 10 Mg/Ml Amp. 1 Ml, Contour. Cell. Yp. , Pack), Urapidil (Province D/In. 25 Mg Amp. 5 Ml), Escitalopram (Tablet In/Film-Coated 10 Mg Bliste
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Eastern Europe
Political Region
Commonwealth of Independent States CIS
Last Date of Bid Submission
07-04-2023
Closed
Work Detail
Mono (P-H D/Inf. 1 Mg/Ml Amp. 5 Ml, Blister Pack (L-Lysine Escinate)), Thioctic Acid (P-H D/Inf. 3 % Amp. 20 Ml, Blister Pack) , Amoxicillin And Beta-Lactamase Inhibitor (Comp. D/Oral. Susp. 250 Mg/5 Ml + 62.5 Mg/5 Ml Fl., D/P 100 Ml Susp.), Magnesium (Different Salts In Combination) (Table . N D/Ing. 2.5 Mg Nebula 2.5 Ml), Tocopherol (Vit E) (Caps. Soft 400 Mg Blister), Ademetionine (Lyophil. D/R-Nu D/In. 500 Mg Fl., In Compl. . With Solution Amp. 5 Ml), Hydazepam (Tablet. 0.02 G Blister), Dexketoprofen (P-H D/In. 50 Mg/2 Ml Amp. 2 Ml, Contour. Charunk. Up.), Dexmedetomidine ( Concentration D/P-Nu D/Inf. 100 Mkg/Ml Amp. 2 Ml), Diphenhydramine (P-N D/In. 10 Mg/Ml Amp. 1 Ml, Contour. Charunk. Yp., Pack), Urapidil (R-H D/In. 25 Mg Amp. 5 Ml), Escitalopram (Tablet. B/Film. Obol. 10 Mg Blister), Anti-D (Rh) Immunoglobulin (R-H D/In. 300 Mkg Amp. 2 Ml), Lactic Acid Producing Organisms, Combinations (Caps. 2 Billion Cfu Fl. P/E), Carbetocin (P-H D/In. 100 Mcg/Ml Fl. 1 Ml), Diclofenac (Eye Drops, P-H 1 Mg/Ml Fl.-Drops. 5 Ml), Dexpanthenol (Gel Och . 50 Mg/G Tube 5 G), Electrolytes In Combination With Other Drugs (P-H D/Inf. Bottle 200 Ml (Xylitol, Sodium Acetate, Sodium Chloride, Calcium Chloride, Potassium Chloride, Magnesium Chloride)), Comb Drug ( Tuba Ointment 40 G (Chloramphenicol, Methyluracil)), Hyaluronidase (Comp. D/R-Nu D/In. 64 Od Fl., Blister In Pack), Comb Drug (Tablet. In/Film. Obol. Kish-Solution Blister) (Magnesium Lactate Dihydrate, Pyridoxine Hydrochloride)), Betahistine (Tablet. 24 Mg Blister, In Box), Methylergometrine (P-H D/In. 0.2 Mg/Ml Amp. 1 Ml), Pitofenone And Analgesics (P-H D/In. Amp. 2 Ml, Contour. Charunk. Top. (Ketorolac Tromethamine, Pitofenone Hydrochloride, Fenpiverinium Bromide)), Procaine (P-H D/Inf. 0.25% Bottle 200 Ml), Procaine (P-H D/In. 20 Mg/Ml Amp. 2 Ml, Contour. Charunk. Yp., Pack), Comb Drug (Ointment Tuba 30 G (Ofloxacin, Lidocaine)), Ipidacrine (P-H D/In. 15 Mg/Ml Amp. 1 Ml, Contour. Charunk. Yp., Pack), Paroxetine (Tab. 20 Mg Blister), Pentoxifylline (P-H D/In. 20 Mg/Ml Amp. 5 Ml, Contour. Charunk. Yp., Pack), Piracetam (P-H D/In. 20 % Amp. 10 Ml, Blister In Pack), Pregabalin (Caps. 75 Mg Contour. Charunk. Up.), Pregabalin (Caps. Solid. 150 Mg Blister), Progesterone (P-H D/In. In Ethyloleate 2.5% Amp. 1 Ml, In Blisters In A Pack), Progesterone (Tablet. Vaginal. 200 Mg Blister, Without Applicator), Electrolytes In Combination With Other Drugs (P-H D/Inf. Fla. 200 Ml (Sorbitol, Sodium Lactate Solution, Sodium Chloride, Calcium Chloride Dihydrate) , Potassium Chloride, Magnesium Chloride Hexahydrate)), Electrolytes In Combination With Other Drugs (P-H D/Inf. Bottle 400 Ml (Sorbitol, Sodium Lactate Solution, Sodium Chloride, Calcium Chloride Dihydrate, Potassium Chloride, Magnesium Chloride Hexahydrate)), Ropivacaine (P-N D/In. 7.5 Mg/Ml Amp. 10 Ml, Contour. Charunk. Yp., Pack), Pitofenone And Analgesics (P-N D/In. Amp. 5 Ml, Blister In Pack ( Metamizol Sodium, Pitofenone Hydrochloride, Fenpiverinium Bromide)), Sulpiride (Tablet. 200 Mg Blister), Saccharated Iron Oxide (P-H For Iv In. 20 Mg/Ml Amp. 5 Ml, Contour. Charunk. Yp., Pack), Thiocolchicoside (P-H D/In. 2 Mg/Ml Amp. 2 Ml), Chloropyramine (P-H D/In. 20 Mg/Ml Amp. 1 Ml, In Pack), Citicoline (P -N D/In. 1000 Mg Amp. 4 Ml, Contour. Charunk. Yp., Pack), Cefixime (Comp. D/Oral. Susp. 100 Mg/5 Ml Fl., D/P 60 Ml Susp.)
Key Value
Tender Value
1,332,428 - UAH
Tender Documents
Global Tender Document
0a19d783-d54d-4aee-aaac-50fc531d568c.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.